Calumet, Inc. CLMT
47.11 USD +0.38 (+0.81%)
Nov 3, 2026, 3:21 PM EST
46.38 Day range 47.57
17.85 52-week range 59.87
- YTD
- +137.09%
- 1 year
- +134.49%
Analyst view
Consensus: buy
Buy
Price target (mean) 55.80 +18.4% upside
Now 47.11
- Target (low)
- 40.00
- Target (mean)
- 55.80
- Target (high)
- 75.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.80 | 1.80 – 1.80 | 0.2048 | +778.9% | 1.34B | +24.6% | 1 |
| Next quarter | 1.27 | 1.27 – 1.27 | -0.1826 | +795.5% | 1.27B | +22.3% | 1 |
| Current year | -1.65 | -1.65 – -1.65 | -0.4731 | -248.8% | 5.09B | +23.0% | 1 |
| Next year | 3.20 | 3.20 – 3.20 | -1.65 | +293.9% | 4.94B | -2.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 18, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 12, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jul 30, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 30, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 12, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jan 30, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 22, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 12, 2025 | UBS | Maintained | Neutral | Neutral |
| May 14, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| May 13, 2025 | B of A Securities | Initiated | — | Buy |
| Apr 30, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 9, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 17, 2025 | UBS | Upgrade | Sell | Neutral |
| Mar 5, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 3, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 12, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 4, 2025 | UBS | Downgrade | Neutral | Sell |
| Jan 13, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 11, 2024 | TD Cowen | Maintained | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | TD Cowen | Maintained | Buy | Buy |
| Aug 5, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 21, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Dec 14, 2023 | Goldman Sachs | Maintained | Buy | Buy |